首页 | 本学科首页   官方微博 | 高级检索  
     

非小细胞肺癌的预后因素及多变量分析
引用本文:王德华 廖松林. 非小细胞肺癌的预后因素及多变量分析[J]. 中华医学杂志, 1997, 77(7): 497-500
作者姓名:王德华 廖松林
作者单位:北京医科大学病理学系,湖北省十堰市郧阳医学院病理教研室,首都医科大学附属北京安贞医院病理科
摘    要:
寻找非小细胞肺癌(NSCLC)独立的预后因素,识别手术后复发和死亡的高危险性病人,以指导临床治疗。方法随访NSCLC病人85例。采用组织学观察、免疫组织化学及聚合酶链反应-单链构象多态性(PCR-SSCP)方法和DNA图象分析技术,采用Cox回归模型,多变量分析了临床、病理及主要生物学等13项因素。结果本组病例中位随访时间为47个月;3年、5年总体生存率分别为66%和61%。Cox回归显示,早期复发和死亡的单变量预后因素(P<0.05)为:淋巴结状况、pTNM分期、瘤栓形成、微血管数目、Ki-67抗原标记率、DNA相对含量以及p53基因突变;其中微血管数目和pTNM分期(均P<0.01)为NSCLC独立的预后因素,并由此建立了NSCLC的复发和死亡预测模型,得出了预后指数(PI)。结论PI可能是临床评价病人预后、识别NSCLC手术后复发的高危险性病人很有实用价值的指标。

关 键 词:非小细胞肺癌  预后  Cox模型

Mulivariate analysis of prognostic factors in non small cell lung cancer
Wang Dehua,Liao Songlin,Gao Zifen,et al.. Mulivariate analysis of prognostic factors in non small cell lung cancer[J]. Zhonghua yi xue za zhi, 1997, 77(7): 497-500
Authors:Wang Dehua  Liao Songlin  Gao Zifen  et al.
Affiliation:Wang Dehua,Liao Songlin,Gao Zifen,et al. Department of Pathology,Beijing Medical University,Beijing 100083
Abstract:
Objectives To find independent prognostic factor of non small cell lung cancer (NSCLC), identify the population with "high risk" of recurrence and death in resected NSCLC, and direct adjuvant therapy for clinical doctors. Methods 85 resected patients from NSCLC were followed up. All patients were subjected to the study by light microscope, immunochemistry, PCR SSCP method, and DNA image analysis. Thirteen clinical, pathological, and biological factors were analysed by Cox regression model. Results The median follow up period was 47 months. The overall 3 year survival rate was 66% and the overall 5 year survival rate 61%. Cox regression showed significant univariate predictors ( P <0.05) of early recurrence and death for NSCLC were lymphnode status, pTNM, tumor emboli, microvessel count, Ki 67 antigen labeling, DNA relative content and p53 gene mutation. Microvessel count ( P <0.001) and pTNM ( P =0.006) were independent predictors of early recurrence and cancer death. According to the multivariate model for predicting early recurrence and cancer death, prognostic index (PI) was calculated. Conclusion The PI may be a useful clinical tool for evaluating prognosis of patients and identifying the population with "high risk" of recurrence and death in NSCLC.
Keywords:Non small cell lung cancer Prognosis Cox model
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号